Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 195641.77 Crore) operating in Pharmaceuticals sector. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 9848.82 Crore, down -.23 % from last quarter Total Income of Rs 9871.26 Crore and up 11.81 % from last year same quarter Total Income of Rs 8808.91 Crore. Company reported net profit after tax of Rs 2088.73 Crore in latest quarter.
Investment Rationale
The brokerage marginally tweaks estimates due to factor in the current quarter’s performance. Retain BUY with a revised target of Rs959/share based on 28xFY23E EPS (earlier: Rs900/share). Key downside risks: Higher than expected pricing pressures in the US, and regulatory hurdles.
Promoter/FII Holdings
Promoters held 54.48 per cent stake in the company as of 30-Sep-2021, while FIIs owned 12.07 per cent, DIIs 21.72 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
